1. Japan

    0 Comments Leave a Comment

    1-15 of 184 1 2 3 4 ... 11 12 13 »

    1. Mentioned In 184 Articles

    9. Caesars: Eldorado Offer Nixed, Icahn's Exit Number May Be A Bridge Too Far At This Stage - Caesars Entertainment Corporation (NASDAQ:CZR)

      Explore Stock Market News & Financial Analysis BoardNews
      Caesars: Eldorado Offer Nixed, Icahn's Exit Number May Be A Bridge Too Far At This Stage - Caesars Entertainment Corporation (NASDAQ:CZR)
      ...l with a partnership in a project in South Korea. It’s a $775m investment that makes much better sense. As to Japan, its prospects rank at the low end of the totem pole of possible awardees of one of the three gaming lic...
      Read Full Article
      Mentions: Management bankruptcy Nasdaq
    17. 1-15 of 184 1 2 3 4 ... 11 12 13 »
  1. Search:

  2. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content

  3. Related Topics

    1. NYT adds tech heavyweights Ito, McAndrews to board
      308 articles also mentioned Board of Directors
    2. Britain to Prosecute Japan's Olympus for Fraud
      245 articles also mentioned CEO
    3. Contrarian investing
      110 articles also mentioned Management
    4. Delta Electronics Announces New Management Team
      92 articles also mentioned Europe
    5. Women Corporate Directors in the Middle East: New Trends Include the Private
      83 articles also mentioned Corporate Governance
    6. Tiffany Announces Stock Repurchase Program; Board Authorizes $300 Million over Three Years
      82 articles also mentioned stock options
    7. A shareholders’ association at last!
      75 articles also mentioned Asia

  4. Quotes about Japan

    1. In corporate Japan, big pay gaps within the same company leads to lower motivation among employees.
      In Japan Firms Have No Plans to Strengthen Governance After Ghosn Arrest
    2. Phathom is well positioned with vonoprazan, a late-stage GI therapeutic, that has achieved clinical and commercial success in Japan.
      In Phathom Pharmaceuticals Announces Leadership Succession Plan and Strengthens Board of Directors with New Appointments
    3. Shareholders have suffered from the subsidization of Ito Yokado for so long that Seven & i is emerging as one of the most crucial tests for the success of corporate governance reform in Japan.
      In Loeb’s Third Point Takes Stake in Japan’s Seven & I Holdings